As reported in Figure 1, mean PON2/3 lactonase activity evaluated in PBMNCs was significantly lower in AD children (0.061 ± 0.002 U/mg) than that in the controls (0.097 ± 0.002 U/mg) (p < 0.001). This evidence concerns the gene PON2 and Alzheimer disease.